Digital Evidence Base

Trusted Knowledge for Informed Decisions

Publish Evidence AI Chat Login
Filters
SDGs
Priority Areas
Research Outcomes
Document Type
Year
4019 results found
Show:
Erratum: Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial (The Lancet (2010) 375(9724) (1447â1456) (S0140673610603078) (10.
2010
DOI: 10.1016/S0140-6736(10)61148-8
Abstract
Diagnostic Value of Plasma C-Type Natriuretic Peptide Levels in Determination of the Duration of Mesenteric Ischaemia : Cardiovascular Topic
Caliskan Ahmet, Demirtas Sinan, Guclu Orkut, Karahan Oguz, Tezcan Orhan, Yavuz Celal, Yazici Suleyman
2014

Objective: Mesenteric arteries release C-type natriureticpeptide (CNP), which hyperpolarises vascular smooth muscle.We measured the levels of this peptide after inducing mesen-teric ischaemia over a series of time intervals, so as …

Abstract
National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links
Phiri Sam, HutchinsonEleanor, Parkhurst Justin, Gibb Di M., Chishinga Nathaniel, Droti Benson, Hoskins Susan
2011

MEDLINE Abstract: BACKGROUND:<BR>Several frameworks have been constructed to analyse the factors which influence and shape the uptake of evidence into policy processes in resource poor settings, yet empirical analyses of …

Abstract
Anemia and transfusion requirements among Ugandan children with severe malaria treated with intravenous artesunate
Namasopo S, Conroy A L, Hawkes M T, Kain K C, Opoka R O, Elphinstone R E, Hume H A
2020
DOI: 10.1080/08880018.2019.1701161

Parenteral artesunate for the treatment of severe malaria in non-immune travelers is associated with late-onset hemolysis. In childrenin sub-Saharan Africa, the hematologic effects of malaria and artesu-nate are less well …

Abstract
Erratum to: Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial
Gupta-Wright Ankur, Fielding Katherine L., van Oosterhout Joep J., Wilson Douglas K., Corbett Elizabeth L., Flach Clare, Reddy Krishna P., Walensky Rochelle P., Peters Jurgens A., Alufandika-Moyo Melanie, Lawn Stephen D.
2016
DOI: 10.1186/s12879-016-1949-5
Abstract
Tackling childhood tuberculosis in Uganda
Green A.
2015
DOI: 10.1016/S2213-2600(15)00107-1
Abstract
Expediting UNIVERSAL first and second-line regimens for all children living with HIV in Africa
Baylor Uganda
Abstract
Humoral Responses to Rv1733c, Rv0081, Rv1735c, and Rv1737c DosR Regulon-Encoded Proteins of Mycobacterium tuberculosis in Individuals with Latent Tuberculosis Infection
Cose Stephen, KimudaSimon G., Nalwoga Angela, Levin Jonathan, Franken Kees L. M. C., Ottenhoff Tom H. M., Elliott Alison M., Andia-Biraro Irene
2017

MEDLINE Abstract: Latent tuberculosis infection (LTBI) is evidence of immunological control of tuberculosis. Dormancy survival regulator (DosR) regulon-encoded proteins may have a role in the maintenance of LTBI. T cell …

Abstract
Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+T-cell counts above 350 cells/ml in rural Uganda
Amanyire G, Kwarisiima D, Kabami J, Chamie G, Jain V, Black D, Kamya M R, Clark T D, Charlebois E D, Havlir D V, Byonanebye D M, Rooney J F
2014
DOI: 10.1097/QAD.0000000000000401

Background: HIV antiretroviral therapy (ART) is being rapidly scaled up in sub-Saharan Africa, including recently patients with CD4+ T-cell counts above 350 cells/μl. However, concerns persist about adherence and virologic …

Abstract
Apabetalone downregulates fibrotic, inflammatory and calcific processes in renal mesangial cells which may contribute to reduced cardiac events observed in ckd patients
Gilham D., Fu L., Rakai B., Wasiak S., Tsujikawa L., Halliday C., Sarsons C., Stotz S., Jahagirdar R., Johansson J., Sweeney M., Wong N., Kalantar-Zadeh K., Kulikowski E.
2021
DOI: 10.1093/ndt/gfab078.008

BACKGROUND AND AIMS: Major adverse cardiac events (MACE) remain a leading cause of mortality in chronic kidney disease (CKD). Apabetalone is an orally available inhibitor of bromodomain & extraterminal (BET) …

Abstract
AI Research Assistant
AI-powered research assistance. Uses the Digital Evidence Base as the Knowledge source.